SCHEMBL9920677

SCHEMBL9920677

Cc1ccc(-c2ccc3ccc4c(-c5ccc(-n6c7ccccc7c7cc(-c8ccccc8-c8ccccc8)ccc76)cc5)ccc5ccc2c3c54)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 5/20 0.36
RXFP1 Q9HBX9 3/20 0.36
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
CYP2C9 P11712 1/20 0.35
HTT P42858 1/20 0.35
PTGER4 P35408 2/20 0.35
NPY5R Q15761 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
RAB9A P51151 1/20 0.33
MCL1 Q07820 1/20 0.32
BAD Q92934 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13872332 0.94 L3MBTL1 (0.39) KDM4EL3MBTL1ATMALDH1A1RXFP1
SCHEMBL9920734 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1RXFP1
SCHEMBL9920658 0.92 FLT3 (0.40) KDM4EL3MBTL1ATMALDH1A1RXFP1
SCHEMBL9920663 0.91 AKR1C4 (0.36) KDM4EL3MBTL1ATMALDH1A1RXFP1
SCHEMBL13872338 0.91 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1RXFP1
SCHEMBL13872342 0.91 HTT (0.38) KDM4EALDH1A1RXFP1AKR1C4AKR1C3
SCHEMBL13872333 0.91 HTT (0.38) KDM4EALDH1A1RXFP1AKR1C4AKR1C3
SCHEMBL13872357 0.91 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1RXFP1
SCHEMBL13872353 0.90 FLT3 (0.39) KDM4EALDH1A1MCL1BADKMT2A
SCHEMBL9920725 0.89 KDM4E (0.39) KDM4EL3MBTL1ATMALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 KDM4E 2433/4885L3MBTL1 283/4885ATM 1983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.